Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis
Editor Note: For more information about this release, please scroll to bottom 
From PR Newswire
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
From Business Wire News Releases
Merck Completes Tender Offer to Acquire Idenix
From Business Wire News Releases
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results
From GlobeNewswire News Releases
Biotechnology Stocks Technical Review -- Research on Medivation, Idenix Pharma, Nanosphere, and Progenics Pharma
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Lawsuit Filed to Halt the Takeover by Merck
San Diego, CA -- (SBWIRE) -- 06/24/2014 -- An investor, who currently holds shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) filed a lawsuit in effort to halt the takeover of Idenix Pharmaceuticals... 
From SBWire - Latest Press Releases
Merck Begins Tender Offer to Acquire Idenix
From Business Wire News Releases
Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors
From Business Wire News Releases
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Idenix Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Merck & Co., Inc.
From Business Wire News Releases
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Investigation of Buyout by Merck
San Diego, CA -- (SBWIRE) -- 06/16/2014 -- An investigation on behalf of investors, who currently hold shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX), was announced concerning whether the takeover... 
From SBWire - Latest Press Releases
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Idenix Pharmaceuticals, Inc. in Connection With The Sale of The Company - IDIX
From PR Newswire
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Idenix Pharmaceuticals, Inc. - IDIX
From PR Newswire
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Idenix Pharmaceuticals Inc. (IDIX) Concerning the Proposed Acquisition by Merck & Co., Inc. (MRK)
From Business Wire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Idenix Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Merck
From Business Wire News Releases
Ryan & Maniskas, LLP Announces Investigation of Idenix Pharmaceuticals Inc.
From PR Newswire
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Idenix Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Merck & Co., Inc.
From Business Wire News Releases
Lifshitz & Miller Law Firm Announces Investigation of American Realty Capital Healthcare Trust, Inc., Hittite Microwave Corporation, Idenix Pharmaceuticals, Inc., LSB Financial Corp., MKTG Inc., Prote
From PR Newswire
IDENIX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
From Business Wire News Releases
Idenix Pharmaceuticals Trust Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Acquisition by Merck
From Business Wire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Idenix Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Merck
From Business Wire News Releases
Merck to Acquire Idenix
From Business Wire News Releases
Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Technical Analysis on Top Gainers -- Research on Idenix Pharma, Senomyx, DepoMed, and Highpower Intl.
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals
Editor Note: For more information about this release, please scroll to bottom 
From PR Newswire
Biotech Stocks on our Radar -- Research on ImmunoGen, Idenix Pharma, Repligen, and Vanda Pharma
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Idenix Pharmaceuticals Reports First Quarter 2014 Financial Results and HCV Pipeline Review
From GlobeNewswire News Releases
Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences
From GlobeNewswire News Releases
Morning Review on Top Gainers -- Research on Peregrine Pharma, Agios Pharma, Idenix Pharma, and Lexicon Pharma
Editor Note: For more information about this release, please scroll to bottom. 
From PR Newswire
Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C
From GlobeNewswire News Releases
Idenix Announces Nucleotide Prodrug (IDX21437) and NS5A Inhibitor (Samatasvir) Poster Presentations at 49th Annual Meeting of the European Association for the Study of the Liver
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.